Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Alternative treatment for cancer [[electronic resource] /] / editors, Ping-Chung Leung, Harry Fong
| Alternative treatment for cancer [[electronic resource] /] / editors, Ping-Chung Leung, Harry Fong |
| Pubbl/distr/stampa | Hackensack, NJ, : World Scientific, c2007 |
| Descrizione fisica | 1 online resource (384 p.) |
| Disciplina | 616.99406 |
| Altri autori (Persone) |
LeungPing-Chung <1941->
FongHarry Hong Sang <1935-> |
| Collana | Annals of traditional Chinese medicine |
| Soggetto topico |
Cancer - Alternative treatment
Medicine, Chinese |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1-281-91876-8
9786611918767 981-270-930-4 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Contents; Contributors; Preface to Series; Preface to Volume 3; Chapter 1 The Scientific Basis of Chinese Medicine and Cancer Care: A Western Medicine Perspective Stephen M. Sagar & Raimond Wong; 1.1 Introduction; 1.2 Cancer as a Systemic Disease; 1.3 The Body-Mind Network; 1.4 Pharmacology of Chinese Herbs; 1.5 Physiology of Acupuncture; 1.6 Roles of TCM in Cancer Supportive Care; 1.7 Conclusions; Acknowledgments; References; Chapter 2 Recent Status and Outlook of Traditional Chinese Medicine in Cancer Treatment Dai-Han Zhou; 2.1 Introduction; 2.2 Methods; 2.3 Results; 2.4 Discussion
ReferencesChapter 3 Chinese Medicine and Cancer Treatment in Hong Kong: A General Review Ping-Chung Leung, Vincent Ooi, Eliza L.-Y. Wong, Wai-Chun Au, Chun-Kwok Wong, Wai-Kei Lam, Sing-Fai Leung & Tony S.-K. Mok; 3.1 Introduction - Cancer and Ancient Chinese Medicine; 3.2 Interest Over the Use of Herbs Against Cancer; 3.3 A Practical Approach to the Clinical Use of Chinese Herbs for Cancer Patients; 3.4 A Clinical Trial Using Herbal Preparation as Supplements to Chemotherapy for Cancer; 3.5 A Clinical Trial Using a Herbal Formula as Supplement to Radiotherapy for Cancer Patients 3.6 A Clinical Trial Using Herbal Preparation as a Palliative Agent in the Treatment of Multiple Bone Metastases3.7 A Clinical Trial Using Herbal Preparation as Preventive Agent for Immuno-Support; 3.8 System Review of Effects of Coriolus on the Survival of Cancer patients; 3.9 Conclusion; References; Chapter 4 Advancements of Ayurveda in Cancer Management with Special Focus on Hepatocellular Carcinoma Premalatha Balachandran; 4.1 Introduction; 4.2 Cancer Definition; 4.2.1 Benign versus malignant tumors; 4.2.2 Classification; 4.2.3 Etiology; 4.3 Ayurveda's Special Focus on Liver Diseases 4.3.1 Description of liver4.4 Neoplasm of the Liver; 4.4.1 Hepatocellular carcinoma; 4.4.1.1 Epidemiology; 4.4.1.2 Pathogenesis and diagnosis; 4.4.1.3 Treatment modalities in modern medicine; 4.4.1.4 Basis for ayurvedic therapy; 4.4.1.5 Ayurvedic treatment modalities; 4.5 Anti-cancer Drugs of Ayurveda Meets Modern Science; 4.5.1 Andrographis paniculata (Kalmegh); 4.5.2 Annona atemoya/ muricata (Sitaphala); 4.5.3 Boerhavia diffusa (Punarnava); 4.5.4 Eclipta alba (Bhringaraj); 4.5.5 Phyllanthus niruri /amarus (Bhumyamalaki); 4.5.6 Picrorrhiza kurroa (Katuki) 4.5.7 Podophyllum hexandrum (Giriparpata)4.5.8 Tinospora cordifolia (Guduchi); 4.5.9 Semecarpus anacardium (Bhallataka); 4.5.10 Hepatoprotective ayurvedic formulations; 4.6 Benefits and Risks of Ayurvedic Medicine in Cancer Care; 4.7 Recommended Research Design; 4.8 Conclusion; References; Chapter 5 Complementary Approaches to Cancer in Italy Ralph W. Moss; 5.1 Introduction; 5.1.1 The Di Bella affair; 5.2 Methods; 5.3 Results; 5.3.1 A visit to Bologna; 5.3.2 Santa Famiglia conference and LSA-CM; 5.4 Discussion; References; Chapter 6 Kampo Treatment for Cancer Kenji Watanabe; 6.1 Introduction 6.2 Prevention of Cancer |
| Record Nr. | UNINA-9910451175903321 |
| Hackensack, NJ, : World Scientific, c2007 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Alternative treatment for cancer [[electronic resource] /] / editors, Ping-Chung Leung, Harry Fong
| Alternative treatment for cancer [[electronic resource] /] / editors, Ping-Chung Leung, Harry Fong |
| Pubbl/distr/stampa | Hackensack, NJ, : World Scientific, c2007 |
| Descrizione fisica | 1 online resource (384 p.) |
| Disciplina | 616.99406 |
| Altri autori (Persone) |
LeungPing-Chung <1941->
FongHarry Hong Sang <1935-> |
| Collana | Annals of traditional Chinese medicine |
| Soggetto topico |
Cancer - Alternative treatment
Medicine, Chinese |
| ISBN | 9789812709301 (eBook) |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Contents; Contributors; Preface to Series; Preface to Volume 3; Chapter 1 The Scientific Basis of Chinese Medicine and Cancer Care: A Western Medicine Perspective Stephen M. Sagar & Raimond Wong; 1.1 Introduction; 1.2 Cancer as a Systemic Disease; 1.3 The Body-Mind Network; 1.4 Pharmacology of Chinese Herbs; 1.5 Physiology of Acupuncture; 1.6 Roles of TCM in Cancer Supportive Care; 1.7 Conclusions; Acknowledgments; References; Chapter 2 Recent Status and Outlook of Traditional Chinese Medicine in Cancer Treatment Dai-Han Zhou; 2.1 Introduction; 2.2 Methods; 2.3 Results; 2.4 Discussion
ReferencesChapter 3 Chinese Medicine and Cancer Treatment in Hong Kong: A General Review Ping-Chung Leung, Vincent Ooi, Eliza L.-Y. Wong, Wai-Chun Au, Chun-Kwok Wong, Wai-Kei Lam, Sing-Fai Leung & Tony S.-K. Mok; 3.1 Introduction - Cancer and Ancient Chinese Medicine; 3.2 Interest Over the Use of Herbs Against Cancer; 3.3 A Practical Approach to the Clinical Use of Chinese Herbs for Cancer Patients; 3.4 A Clinical Trial Using Herbal Preparation as Supplements to Chemotherapy for Cancer; 3.5 A Clinical Trial Using a Herbal Formula as Supplement to Radiotherapy for Cancer Patients 3.6 A Clinical Trial Using Herbal Preparation as a Palliative Agent in the Treatment of Multiple Bone Metastases3.7 A Clinical Trial Using Herbal Preparation as Preventive Agent for Immuno-Support; 3.8 System Review of Effects of Coriolus on the Survival of Cancer patients; 3.9 Conclusion; References; Chapter 4 Advancements of Ayurveda in Cancer Management with Special Focus on Hepatocellular Carcinoma Premalatha Balachandran; 4.1 Introduction; 4.2 Cancer Definition; 4.2.1 Benign versus malignant tumors; 4.2.2 Classification; 4.2.3 Etiology; 4.3 Ayurveda's Special Focus on Liver Diseases 4.3.1 Description of liver4.4 Neoplasm of the Liver; 4.4.1 Hepatocellular carcinoma; 4.4.1.1 Epidemiology; 4.4.1.2 Pathogenesis and diagnosis; 4.4.1.3 Treatment modalities in modern medicine; 4.4.1.4 Basis for ayurvedic therapy; 4.4.1.5 Ayurvedic treatment modalities; 4.5 Anti-cancer Drugs of Ayurveda Meets Modern Science; 4.5.1 Andrographis paniculata (Kalmegh); 4.5.2 Annona atemoya/ muricata (Sitaphala); 4.5.3 Boerhavia diffusa (Punarnava); 4.5.4 Eclipta alba (Bhringaraj); 4.5.5 Phyllanthus niruri /amarus (Bhumyamalaki); 4.5.6 Picrorrhiza kurroa (Katuki) 4.5.7 Podophyllum hexandrum (Giriparpata)4.5.8 Tinospora cordifolia (Guduchi); 4.5.9 Semecarpus anacardium (Bhallataka); 4.5.10 Hepatoprotective ayurvedic formulations; 4.6 Benefits and Risks of Ayurvedic Medicine in Cancer Care; 4.7 Recommended Research Design; 4.8 Conclusion; References; Chapter 5 Complementary Approaches to Cancer in Italy Ralph W. Moss; 5.1 Introduction; 5.1.1 The Di Bella affair; 5.2 Methods; 5.3 Results; 5.3.1 A visit to Bologna; 5.3.2 Santa Famiglia conference and LSA-CM; 5.4 Discussion; References; Chapter 6 Kampo Treatment for Cancer Kenji Watanabe; 6.1 Introduction 6.2 Prevention of Cancer |
| Record Nr. | UNINA-9910784706603321 |
| Hackensack, NJ, : World Scientific, c2007 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Alternative treatment for cancer [[electronic resource] /] / editors, Ping-Chung Leung, Harry Fong
| Alternative treatment for cancer [[electronic resource] /] / editors, Ping-Chung Leung, Harry Fong |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | Hackensack, NJ, : World Scientific, c2007 |
| Descrizione fisica | 1 online resource (384 p.) |
| Disciplina | 616.99406 |
| Altri autori (Persone) |
LeungPing-Chung <1941->
FongHarry Hong Sang <1935-> |
| Collana | Annals of traditional Chinese medicine |
| Soggetto topico |
Cancer - Alternative treatment
Medicine, Chinese |
| ISBN | 9789812709301 (eBook) |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Contents; Contributors; Preface to Series; Preface to Volume 3; Chapter 1 The Scientific Basis of Chinese Medicine and Cancer Care: A Western Medicine Perspective Stephen M. Sagar & Raimond Wong; 1.1 Introduction; 1.2 Cancer as a Systemic Disease; 1.3 The Body-Mind Network; 1.4 Pharmacology of Chinese Herbs; 1.5 Physiology of Acupuncture; 1.6 Roles of TCM in Cancer Supportive Care; 1.7 Conclusions; Acknowledgments; References; Chapter 2 Recent Status and Outlook of Traditional Chinese Medicine in Cancer Treatment Dai-Han Zhou; 2.1 Introduction; 2.2 Methods; 2.3 Results; 2.4 Discussion
ReferencesChapter 3 Chinese Medicine and Cancer Treatment in Hong Kong: A General Review Ping-Chung Leung, Vincent Ooi, Eliza L.-Y. Wong, Wai-Chun Au, Chun-Kwok Wong, Wai-Kei Lam, Sing-Fai Leung & Tony S.-K. Mok; 3.1 Introduction - Cancer and Ancient Chinese Medicine; 3.2 Interest Over the Use of Herbs Against Cancer; 3.3 A Practical Approach to the Clinical Use of Chinese Herbs for Cancer Patients; 3.4 A Clinical Trial Using Herbal Preparation as Supplements to Chemotherapy for Cancer; 3.5 A Clinical Trial Using a Herbal Formula as Supplement to Radiotherapy for Cancer Patients 3.6 A Clinical Trial Using Herbal Preparation as a Palliative Agent in the Treatment of Multiple Bone Metastases3.7 A Clinical Trial Using Herbal Preparation as Preventive Agent for Immuno-Support; 3.8 System Review of Effects of Coriolus on the Survival of Cancer patients; 3.9 Conclusion; References; Chapter 4 Advancements of Ayurveda in Cancer Management with Special Focus on Hepatocellular Carcinoma Premalatha Balachandran; 4.1 Introduction; 4.2 Cancer Definition; 4.2.1 Benign versus malignant tumors; 4.2.2 Classification; 4.2.3 Etiology; 4.3 Ayurveda's Special Focus on Liver Diseases 4.3.1 Description of liver4.4 Neoplasm of the Liver; 4.4.1 Hepatocellular carcinoma; 4.4.1.1 Epidemiology; 4.4.1.2 Pathogenesis and diagnosis; 4.4.1.3 Treatment modalities in modern medicine; 4.4.1.4 Basis for ayurvedic therapy; 4.4.1.5 Ayurvedic treatment modalities; 4.5 Anti-cancer Drugs of Ayurveda Meets Modern Science; 4.5.1 Andrographis paniculata (Kalmegh); 4.5.2 Annona atemoya/ muricata (Sitaphala); 4.5.3 Boerhavia diffusa (Punarnava); 4.5.4 Eclipta alba (Bhringaraj); 4.5.5 Phyllanthus niruri /amarus (Bhumyamalaki); 4.5.6 Picrorrhiza kurroa (Katuki) 4.5.7 Podophyllum hexandrum (Giriparpata)4.5.8 Tinospora cordifolia (Guduchi); 4.5.9 Semecarpus anacardium (Bhallataka); 4.5.10 Hepatoprotective ayurvedic formulations; 4.6 Benefits and Risks of Ayurvedic Medicine in Cancer Care; 4.7 Recommended Research Design; 4.8 Conclusion; References; Chapter 5 Complementary Approaches to Cancer in Italy Ralph W. Moss; 5.1 Introduction; 5.1.1 The Di Bella affair; 5.2 Methods; 5.3 Results; 5.3.1 A visit to Bologna; 5.3.2 Santa Famiglia conference and LSA-CM; 5.4 Discussion; References; Chapter 6 Kampo Treatment for Cancer Kenji Watanabe; 6.1 Introduction 6.2 Prevention of Cancer |
| Record Nr. | UNINA-9910821783903321 |
| Hackensack, NJ, : World Scientific, c2007 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Cancer and complementary health practices [[electronic resource]]
| Cancer and complementary health practices [[electronic resource]] |
| Edizione | [Updated Mar. 2012.] |
| Pubbl/distr/stampa | [Bethesda, MD] : , : U.S. Dept. of Health and Human Services, National Institutues of Health, National Center for Complementary and Alternative Medicine, , [2012] |
| Descrizione fisica | 1 online resource (9 pages) |
| Collana | Get the facts |
| Soggetto topico |
Cancer - Alternative treatment
Cancer - Alternative treatment - United States Cancer - Alternative treatment - Research - United States Cancer - Prevention |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910702104103321 |
| [Bethesda, MD] : , : U.S. Dept. of Health and Human Services, National Institutues of Health, National Center for Complementary and Alternative Medicine, , [2012] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Cancer and complementary medicine : your guide to smart choices in symptom management / / by Colleen O. Lee and Georgia M. Decker
| Cancer and complementary medicine : your guide to smart choices in symptom management / / by Colleen O. Lee and Georgia M. Decker |
| Autore | Lee Colleen O. |
| Pubbl/distr/stampa | Pittsburgh, Pennsylvania : , : Oncology Nursing Society, , 2012 |
| Descrizione fisica | 1 online resource (144 p.) |
| Disciplina | 616.99/4 |
| Soggetto topico | Cancer - Alternative treatment |
| Soggetto genere / forma | Electronic books. |
| ISBN | 1-935864-39-4 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | ""Cancer and Complementary Medicine: Your Guide to Smart Choices in Symptom Management""; ""Chapter 1. What Is Complementary and Alternative ""; ""Chapter 2. Types of Complementary and Alternative ""; ""Chapter 3. Herbs, Vitamins, and Supplements""; ""Chapter 4. Symptom Management With Complementary ""; ""Chapter 5. Complementary and Alternative Medicine ""; ""Chapter 6. Healthy Living""; ""For More Information"" |
| Record Nr. | UNINA-9910465252903321 |
Lee Colleen O.
|
||
| Pittsburgh, Pennsylvania : , : Oncology Nursing Society, , 2012 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Cancer and complementary medicine : your guide to smart choices in symptom management / / by Colleen O. Lee and Georgia M. Decker
| Cancer and complementary medicine : your guide to smart choices in symptom management / / by Colleen O. Lee and Georgia M. Decker |
| Autore | Lee Colleen O. |
| Pubbl/distr/stampa | Pittsburgh, Pennsylvania : , : Oncology Nursing Society, , 2012 |
| Descrizione fisica | 1 online resource (144 p.) |
| Disciplina | 616.99/4 |
| Soggetto topico | Cancer - Alternative treatment |
| ISBN | 1-935864-39-4 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | ""Cancer and Complementary Medicine: Your Guide to Smart Choices in Symptom Management""; ""Chapter 1. What Is Complementary and Alternative ""; ""Chapter 2. Types of Complementary and Alternative ""; ""Chapter 3. Herbs, Vitamins, and Supplements""; ""Chapter 4. Symptom Management With Complementary ""; ""Chapter 5. Complementary and Alternative Medicine ""; ""Chapter 6. Healthy Living""; ""For More Information"" |
| Record Nr. | UNINA-9910792211203321 |
|
Lee Colleen O.
|
||
| Pittsburgh, Pennsylvania : , : Oncology Nursing Society, , 2012 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Cancer and complementary medicine : your guide to smart choices in symptom management / / by Colleen O. Lee and Georgia M. Decker
| Cancer and complementary medicine : your guide to smart choices in symptom management / / by Colleen O. Lee and Georgia M. Decker |
| Autore | Lee Colleen O. |
| Pubbl/distr/stampa | Pittsburgh, Pennsylvania : , : Oncology Nursing Society, , 2012 |
| Descrizione fisica | 1 online resource (144 p.) |
| Disciplina | 616.99/4 |
| Soggetto topico | Cancer - Alternative treatment |
| ISBN | 1-935864-39-4 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | ""Cancer and Complementary Medicine: Your Guide to Smart Choices in Symptom Management""; ""Chapter 1. What Is Complementary and Alternative ""; ""Chapter 2. Types of Complementary and Alternative ""; ""Chapter 3. Herbs, Vitamins, and Supplements""; ""Chapter 4. Symptom Management With Complementary ""; ""Chapter 5. Complementary and Alternative Medicine ""; ""Chapter 6. Healthy Living""; ""For More Information"" |
| Record Nr. | UNINA-9910822678403321 |
|
Lee Colleen O.
|
||
| Pittsburgh, Pennsylvania : , : Oncology Nursing Society, , 2012 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Cannabis and cannabinoid-based medicines in cancer care : a comprehensive guide to medical management / / Claude Cyr [and three others]
| Cannabis and cannabinoid-based medicines in cancer care : a comprehensive guide to medical management / / Claude Cyr [and three others] |
| Autore | Cyr Claude <1957-> |
| Pubbl/distr/stampa | Cham, Switzerland : , : Springer, , [2022] |
| Descrizione fisica | 1 online resource (325 pages) : illustrations |
| Disciplina | 616.99406 |
| Soggetto topico |
Cancer - Alternative treatment
Cancer - Treatment |
| ISBN | 3-030-89918-7 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Intro -- Preface -- Acknowledgments -- About the Book -- Terminology Used in this Textbook -- Contents -- List of Figures -- List of Tables -- Contributors -- Chapter 1: Overview of the Endocannabinoid System and Endocannabinoidome -- 1.1 Introduction -- 1.2 Terminology -- 1.3 The Canonical Cannabinoid Receptors: CB1 and CB2 -- 1.4 Heterodimers and Membrane Influences on Canonical Cannabinoid Signaling -- 1.5 Constitutive Activation of Canonical Receptors -- 1.6 Allosteric Modulation -- 1.7 Canonical Cannabinoid Receptor Locations -- 1.8 Neurophysiology of Canonical Receptor Activation -- 1.9 Orphan Receptors -- 1.10 Endocannabinoid Ion Channels: Transient Receptor Potential Channels -- 1.11 Interactions Between the Endocannabinoid and Endogenous Opioid Systems -- 1.12 N-Methyl-D-aspartate Receptors and Cannabinoids -- 1.13 Cannabinoid Ligands -- 1.14 Synthesis and Catabolism of Anandamide (AEA) -- 1.15 Synthesis and Catabolism of 2-Arachidonoyl Glycerol (2-AG) -- 1.16 Tetrahydrocannabinol -- 1.17 Tetrahydrocannabinol and the Eicosanoid System -- 1.18 Intracellular Binding Proteins -- 1.19 Phytocannabinoids and P-Glycoprotein and Multidrug Transports -- 1.20 N-Acylethanolamines -- 1.21 Conclusion -- References -- Chapter 2: Cannabinoid-Based Medicine: Pharmacology and Drug Interactions -- 2.1 Introduction -- 2.2 Terminology -- 2.3 Endocannabinoids and Drug Interactions -- 2.4 Endocannabinoids, Cyclooxygenase, and Drug Interactions -- 2.5 Endocannabinoids and Glucocorticoids -- 2.6 Endocannabinoids and Opioids -- 2.7 Clinical and Animal Studies of Cannabinoid Opioid Interactions -- 2.8 Endocannabinoids, Anxiety and Depression -- 2.8.1 Endocannabinoid "Tone": Beyond the Theory -- 2.9 Endocannabinoids and Post-traumatic Stress Disorder -- 2.10 Endocannabinoid System Disruptions and Potential Impact on Treatment with Antipsychotics.
2.11 The use of Phytoannabinoids as Antipsychotics -- 2.12 Omega-3 Fatty Acids and effects on the Endocannabinoid System -- 2.13 Phytocannabinoid Pharmacokinetics: THC -- 2.14 Phytocannabinoid Pharmacokinetics: CBD -- 2.15 Cannabidiol and Efflux Pumps -- 2.16 Pharmacokinetics of Approved Cannabinoids -- 2.17 Pharmacokinetic Cannabis-Drug Interactions -- 2.18 Pharmacokinetic Cannabis-Drug Interactions: Relevant Examples -- 2.18.1 Corticosteroids -- 2.18.2 Nonsteroidal Anti-inflammatory Drugs -- 2.18.3 Opioids -- 2.18.4 Antidepressants -- 2.18.5 Janus Kinase Inhibitors -- 2.18.6 Antipsychotics -- 2.18.7 Anticonvulsants -- 2.18.8 Benzodiazepines -- 2.18.9 Ethanol -- 2.18.10 Anticoagulants -- 2.18.11 Antiplatelet Medications -- 2.18.12 HIV Medications -- 2.18.13 Theophylline -- 2.18.14 Chemotherapy -- 2.19 Conclusion -- References -- Chapter 3: Future Therapeutic Potential of Synthetic Cannabinoids and Endocannabinoid System Modulators -- 3.1 Introduction -- 3.2 Terminology -- 3.3 Part 1: Synthetic Cannabinoids -- 3.3.1 Synthetic Cannabinoid Use in the Community -- 3.3.2 Pharmacology -- 3.3.2.1 Pharmacodynamics of Synthetic Cannabinoids -- 3.3.2.2 Potential Uses of Synthetic Cannabinoids: Anticancer Activity -- 3.3.2.3 Synthetic Cannabinoid Toxicity -- 3.3.2.4 Withdrawal -- 3.3.3 Conclusion -- 3.4 Part 2: Palmitoylethanolamide (PEA) and the Role of Future Endocannabinoid Modulators in Cancer Care -- 3.4.1 Pharmacodynamics -- 3.4.2 Pharmacokinetics -- 3.4.3 Safety -- 3.5 Conclusion -- References (Synthetic Cannabinoids) -- References (Palmitoylethanolamide Pharmacology Efficacy and Safety) -- Chapter 4: Cannabinoid-Based Medicines as Cancer Therapy -- 4.1 Introduction -- 4.2 Terminology -- 4.3 Antineoplastic Activity of Different Cannabis Formulations -- 4.4 Cannabinoids and Graft Versus Host Disease -- 4.5 Cannabinoids and Immune Checkpoint Inhibitors. 4.6 Using High-Dose Cannabinoids to Treat Cancer (Phoenix Tears/Rick Simpson Oil) -- 4.7 Hail Mary Pass -- 4.8 Conclusion -- References -- Chapter 5: Cannabinoid-Based Medicines and Cancer Symptom Management -- 5.1 Introduction -- 5.2 Terminology -- 5.3 Chemotherapy-Induced Nausea and Vomiting -- 5.4 Appetite Stimulation -- 5.5 Pain -- 5.6 Sleep -- 5.7 Drug-Sparing Effects -- 5.8 Topical Applications for Wound Healing and Analgesia -- 5.9 Multimodal Symptom Treatment in Advanced Cancer -- 5.10 Conclusion -- References -- Chapter 6: Patient Evaluation: Precautions and Managing Expectations -- 6.1 Introduction -- 6.2 Terminology -- 6.3 General Considerations -- 6.4 Risks of Cannabis Use -- 6.5 Potential Increased Cancer Risk with Cannabis Use -- 6.6 Contraindications and Precautions -- 6.7 Managing Physician Expectations -- 6.8 Managing Patient Expectations -- 6.9 Patient Evaluation -- 6.10 The Initial Interview: Key Clinical Questions and Commentary -- 6.11 Detailed Medical History -- 6.11.1 Neurological Effects and Driving Performance -- 6.11.2 Cardiovascular Effects -- 6.11.3 Pulmonary Effects -- 6.11.4 Gastrointestinal Effects -- 6.11.5 Immune System Modulatory Effects -- 6.12 Detailed Psychiatric History -- 6.12.1 Screening for Clinical High Risk for Psychosis (CHR) -- 6.12.2 Possible Protective Effects of CBD in THC-Induced Psychotic-Like Symptoms -- 6.12.3 Anxiety and Depression -- 6.12.4 Bipolar Disease -- 6.12.5 Post-traumatic Stress Disorder -- 6.12.6 Addiction Issues -- 6.12.7 Tolerance -- 6.12.8 Use of Cannabis in Mild Cognitive Impairment or Dementia -- 6.13 Dealing with Trauma-Sensitive Patients -- 6.14 Medication History -- 6.15 Cannabis History -- 6.16 Conclusion -- References -- Chapter 7: Choosing a Product, Route of Administration, Initial Dosage, Titration, Monitoring and Management of Adverse Effects -- 7.1 Introduction. 7.2 Terminology -- 7.3 General Considerations -- 7.4 Review of the Principal Active Ingredients of Cannabis -- 7.4.1 CBD -- 7.4.2 THC -- 7.4.3 THCA, CBDA, and Other Secondary Cannabinoids -- 7.5 Overview of the Main Routes of Administration of Cannabis Products -- 7.5.1 Oral Ingestion -- 7.5.2 Oromucosal Ingestion -- 7.5.3 Inhalation -- 7.5.3.1 Inhalation Techniques (Smoke or Vapor) -- 7.5.3.2 Current Challenges for Calculating a Precise Dose of THC Using Dried Cannabis for Inhalation -- 7.5.4 Topical and Transdermal -- 7.5.5 Intra-rectal and Vaginal (Suppositories) -- 7.6 Considering the Initial Use of Approved Pharmaceutical Cannabinoids -- 7.7 Choosing a Cannabis Formulation -- 7.7.1 Word of Caution on Product Labeling -- 7.7.2 Regarding the Therapeutic Dose of THC -- 7.7.3 Regarding the Protective Effects of CBD on THC Psychoactivity -- 7.8 Cannabinoid Metabolism: Clinical Considerations Between Inhaled and Oral Routes of Administration -- 7.9 Treatment Selection According to Symptom or Clinical Setting -- 7.10 Precise Dosing Recommendations -- 7.10.1 Initial CBD Dosing -- 7.10.2 Initial THC Dosing -- 7.10.3 Considering Microgram THC Dosing -- 7.10.4 Proposed Dosing Protocols from Consensus Groups -- 7.10.5 Considering the Toxic Psychosis Threshold of THC -- 7.10.6 Considering the Use of High-Potency Extracts (Rick Simpson Oil, RSO, Phoenix Tears) -- 7.11 Dealing with Hospitalized Patients Already Taking Cannabinoid-Based Medicines -- 7.12 Estimating the Dose of THC in Unsupervised Patients -- 7.13 Patient Monitoring, Record Keeping, and Follow-Up Visits -- 7.13.1 Reporting Cannabis Side Effects -- 7.14 Overview of Cannabis Use Disorder and Cannabis Withdrawal Syndrome -- 7.15 Conclusion -- 7.16 Chapter Summary -- References -- Chapter 8: Psychoactive Effects of Cannabinoid-Based Medicines: Exploration and Inquiry -- 8.1 Introduction. 8.2 Terminology -- 8.3 Cannabis Psychoactivity: Current Challenges -- 8.3.1 The Complicated Social, Cultural, and Spiritual History of Cannabis Psychoactivity -- 8.3.2 The Evidence Remains Mostly Anecdotal -- 8.3.3 Our Understanding of the Neurocognitive Effects of THC Has Only Just Begun -- 8.3.4 Management Guidelines for Cannabis Psychoactivity Are Not Available -- 8.3.5 Cannabis Psychoactivity Is Common in Medical Cannabis Patients -- 8.3.6 Avoiding Psychoactivity Is Possible, but Difficult...for Now -- 8.3.7 Precise Dosing Guidelines Are Only Beginning to Emerge -- 8.3.8 Prior Experience with Cannabis May Influence Tolerance to Psychoactivity and Even Psychotic-Like Reactions -- 8.4 Basic Precautions -- 8.4.1 Introducing Cannabis Early in the Course of Life-Limiting Illnesses -- 8.4.2 Preventing Involuntary Intoxications -- 8.4.3 Low Initial THC Dosing: The Cornerstone of Harm Reduction -- 8.4.4 Route of Administration: Oral Versus Inhaled -- 8.5 Preparing Patients for Cannabis Psychoactivity -- 8.5.1 Set and Setting -- 8.5.2 Integration -- 8.5.3 Trauma Sensitivity -- 8.6 Dealing with an Involuntary Intoxication (Bad Trip) -- 8.7 Overview of the Specific Neurocognitive Effects Associated with Cannabis Psychoactivity -- 8.7.1 Slowed Down Perception of Time -- 8.7.2 Metacognition: Thinking About Thinking -- 8.7.3 Metacognition Versus Mind Wandering -- 8.7.4 Metacognition Versus Insight -- 8.7.5 Introspective and Mystical/Spiritual Reflections -- 8.7.6 Reduced Working Memory and Divided Attention -- 8.7.7 Heightened Sense of Awareness and Nonspecific Amplification: The Effects of THC on the Triad Network - Default Mode, Salience, and Central Executive -- 8.7.7.1 The Default Mode Network (DMN) -- 8.7.7.2 The Central Executive Network (CEN) -- 8.7.7.3 The Salience Network (SN) -- 8.7.7.4 Psychotomimetic Properties of THC: The Aberrant Salience Model. 8.7.8 Aversive Memory Extinction. |
| Record Nr. | UNINA-9910544855803321 |
|
Cyr Claude <1957->
|
||
| Cham, Switzerland : , : Springer, , [2022] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Complementary and alternative medicine in cancer treatment [[electronic resource] ] : questions and answers
| Complementary and alternative medicine in cancer treatment [[electronic resource] ] : questions and answers |
| Pubbl/distr/stampa | [Bethesda, Md.] : , : National Cancer Institute, , [2006] |
| Descrizione fisica | 7 pages : digital, PDF file |
| Collana | Fact sheet |
| Soggetto topico |
Cancer - Alternative treatment
Cancer - Treatment |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Complementary and Alternative Medicine in Cancer Treatment |
| Record Nr. | UNINA-9910698577203321 |
| [Bethesda, Md.] : , : National Cancer Institute, , [2006] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Complementary and integrative medicine in cancer care and prevention [[electronic resource] ] : foundation and evidence-based interventions / / editor, Marc S. Micozzi
| Complementary and integrative medicine in cancer care and prevention [[electronic resource] ] : foundation and evidence-based interventions / / editor, Marc S. Micozzi |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | New York, : Springer Pub. Co., c2007 |
| Descrizione fisica | 1 online resource (502 p.) |
| Disciplina | 616.99/406 |
| Altri autori (Persone) | MicozziMarc S. <1953-> |
| Collana | Springer Series on Medical Education |
| Soggetto topico |
Cancer - Alternative treatment
Internal medicine |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1-281-81274-9
9786611812744 0-8261-0308-1 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Contents; List of Figures & Illustrations; List of Tables; Contributors; Preface; Part 1: Biology and Ecology of Cancer; Part 2: Mind/Body Approaches; Part 3: Diet, Nutrition, and Natural Products; Part 4: Alternative Systems of Medicine; Part 5: Alternative Therapies and Practices; Index |
| Record Nr. | UNINA-9910454243003321 |
| New York, : Springer Pub. Co., c2007 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
